Suppr超能文献

ABCC10 的遗传变异与新型替诺福韦转运体有关,与肾小管功能障碍有关。

Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction.

机构信息

National Institute for Health Research Biomedical Research Centre, Royal Liverpool Hospital, UK.

出版信息

J Infect Dis. 2011 Jul 1;204(1):145-53. doi: 10.1093/infdis/jir215.

Abstract

BACKGROUND

Tenofovir (TFV) causes kidney tubular dysfunction (KTD) in some patients, but the mechanism is poorly understood. Genetic variants in TFV transporters are implicated; we explored whether ABCC10 transports TFV and whether ABCC10 single-nucleotide polymorphisms (SNPs) are associated with KTD.

METHODS

TFV accumulation was assessed in parental and ABCC10-transfected HEK293 cells (HEK293-ABCC10), CD4(+) cells and monocyte-derived macrophages (MDMs). Substrate specificity was confirmed by cepharanthine (ABCC10 inhibitor) and small interfering RNA (siRNA) studies. Fourteen SNPs in ABCC10 were genotyped in human immunodeficiency virus-positive patients with KTD (n = 19) or without KTD (controls; n = 96). SNP and haplotype analysis was performed using Haploview.

RESULTS

TFV accumulation was significantly lower in HEK293-ABCC10 cell lines than in parental HEK293 cells (35% lower; P = .02); this was reversed by cepharanthine. siRNA knockdown of ABCC10 resulted in increased accumulation of TFV in CD4(+) cells (18%; P = .04) and MDMs (25%; P = .04). Two ABCC10 SNPs (rs9349256: odds ratio [OR], 2.3; P = .02; rs2125739, OR, 2.0; P = .05) and their haplotype (OR, 2.1; P = .05) were significantly associated with KTD. rs9349256 was associated with urine phosphorus wasting (P = .02) and β2 microglobulinuria (P = .04).

CONCLUSIONS

TFV is a substrate for ABCC10, and genetic variability within the ABCC10 gene may influence TFV renal tubular transport and contribute to the development of KTD. These results need to be replicated in other cohorts.

摘要

背景

替诺福韦(TFV)在一些患者中引起肾小管功能障碍(KTD),但其机制尚不清楚。TFV 转运体的遗传变异与此有关;我们探讨了 ABCC10 是否转运 TFV,以及 ABCC10 单核苷酸多态性(SNP)是否与 KTD 相关。

方法

在亲本 HEK293 细胞(HEK293-ABCC10)、CD4+细胞和单核细胞衍生的巨噬细胞(MDM)中评估 TFV 的积累。通过 cepharanthine(ABCC10 抑制剂)和小干扰 RNA(siRNA)研究证实了底物特异性。对 KTD(n = 19)或无 KTD(对照;n = 96)的人类免疫缺陷病毒阳性患者的 14 个 ABCC10 SNP 进行基因分型。使用 Haploview 进行 SNP 和单倍型分析。

结果

与亲本 HEK293 细胞相比,HEK293-ABCC10 细胞系中 TFV 的积累明显降低(低 35%;P =.02);这可以通过 cepharanthine 逆转。ABCC10 的 siRNA 敲低导致 CD4+细胞(18%;P =.04)和 MDM(25%;P =.04)中 TFV 的积累增加。两个 ABCC10 SNP(rs9349256:比值比[OR],2.3;P =.02;rs2125739,OR,2.0;P =.05)及其单倍型(OR,2.1;P =.05)与 KTD 显著相关。rs9349256 与尿磷排泄增加(P =.02)和β2 微球蛋白尿(P =.04)有关。

结论

TFV 是 ABCC10 的底物,ABCC10 基因内的遗传变异可能影响 TFV 肾小管转运,并导致 KTD 的发生。这些结果需要在其他队列中复制。

相似文献

10
Pharmacogenetics of tenofovir treatment.替诺福韦治疗的药物遗传学。
Pharmacogenomics. 2009 Oct;10(10):1675-85. doi: 10.2217/pgs.09.115.

引用本文的文献

3

本文引用的文献

2
Pharmacogenetics of tenofovir treatment.替诺福韦治疗的药物遗传学。
Pharmacogenomics. 2009 Oct;10(10):1675-85. doi: 10.2217/pgs.09.115.
5
The nephrotoxic effects of HAART.HAART 的肾毒性作用。
Nat Rev Nephrol. 2009 Oct;5(10):563-73. doi: 10.1038/nrneph.2009.142.
6
Tenofovir-associated renal and bone toxicity.替诺福韦相关的肾毒性和骨毒性。
HIV Med. 2009 Sep;10(8):482-7. doi: 10.1111/j.1468-1293.2009.00716.x. Epub 2009 May 6.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验